HRMY
Harmony Biosciences Holdings Inc

17,070
Loading...
Loading...
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company, which engages in the provision of development and commercialization of therapies for the treatment of neurological disorders. Its product, WAKIX, is a molecule with a novel mechanism of action designed to increase histamine signaling in the brain by binding to H3 receptors. The company was founded by Jeffrey S. Aronin on July 25, 2017 and is headquartered in Plymouth Meeting, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
268

Frequently Asked Questions

What is Market Cap of Harmony Biosciences Holdings Inc?
What is the 52-week high for Harmony Biosciences Holdings Inc?
What is the 52-week low for Harmony Biosciences Holdings Inc?
What is Harmony Biosciences Holdings Inc stock price today?
What was Harmony Biosciences Holdings Inc stock price yesterday?
What is the PE ratio of Harmony Biosciences Holdings Inc?
What is the Price-to-Book ratio of Harmony Biosciences Holdings Inc?
What is the 50-day moving average of Harmony Biosciences Holdings Inc?
How many employess does Harmony Biosciences Holdings Inc has?

Latest HRMY News

View

Advertisement. Remove ads.

Advertisement. Remove ads.